Founders Fund VI Management LLC purchased a new stake in shares of Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 110,023 shares of the company’s stock, valued at approximately $175,000. Cyclo Therapeutics comprises […]